Kantar Health Oncology – broad and unparalleled global reach coupled with deep local knowledge

Colorectal Cancer – a global view on standards of care and patient outcomes

We have robust and clinically rich oncology data in all major regions of the world. We’ve highlighted a portion of colorectal cancer (CRC) data in Japan, Germany, China, Brazil and the United States from several of our best-in-class databases: National Health and Wellness Survey (NHWS), Epi Database® and CancerMPact®. Click on the tabs below to reveal data and our synopses.


  • Demographics and Data
    • Incidence
    • Incidence Rank
    • 5-Year Prevalence
  • Health and Lifestyle
    • Comorbidities, Ulcerative Colitis
    • Comorbidities, Crohn’s Disease
    • Comorbidities, Diabetes (Type 2)
    • Drink Alcohol
    • Ever Smoked Cigarettes
    • Currently Smoke Cigarettes
    • Obese (BMI ≥ 30)
    • Exercise
  • Patient Background
    • Mean Age
    • Employed Full-Time
    • Sex (Male)
    • Sex (Female)
  • Early-Stage Treatment
    • Stage I Colon
    • Stage II Colon
    • Stage III Colon
    • Stage I Rectal
    • Stage II Rectal
    • Stage III Rectal
  • Late-Stage Treatment
    • First-Line, RAS Wildtype
    • First-Line, RAS Mutant
    • Second-Line, RAS Wildtype
    • Second-Line, RAS Mutant
    • Third-Line, RAS Wildtype
    • Third-Line, RAS Mutant
    • Fourth-Line, RAS Wildtype
    • Fourth-Line, RAS Mutant
  • Biomarker Histology
    • % of Patients Whose Tumors Harbor a RAS Mutation
© Kantar Health 2011-2015. NHWS, Epi Database® and CancerMPact®

To learn more about our oncology-related products and services, contact us.